258 related articles for article (PubMed ID: 2895586)
1. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
[TBL] [Abstract][Full Text] [Related]
2. Peripheral modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: cholinergic mechanisms.
Wager-Pagé SA; Raizada E; Veale W; Davison JS
Can J Physiol Pharmacol; 1993; 71(10-11):768-75. PubMed ID: 8143235
[TBL] [Abstract][Full Text] [Related]
3. Peptide YY inhibits gastric acid secretion stimulated by the autonomic nervous system.
Clave P; Lluis F; Thompson JC; Greeley GH
Biol Signals; 1992; 1(1):40-5. PubMed ID: 1364034
[TBL] [Abstract][Full Text] [Related]
4. Effect of peptide YY on insulin release stimulated by 2-deoxyglucose and neuropeptides in dogs.
Guo YS; Singh P; DeBouno JF; Thompson JC
Pancreas; 1988; 3(2):128-34. PubMed ID: 3287367
[TBL] [Abstract][Full Text] [Related]
5. Biological actions of peptide YY: effects on endocrine pancreas, pituitary-adrenal axis, and plasma catecholamine concentrations in the dog.
Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Mizuno N; Baba S
Horm Metab Res; 1987 Aug; 19(8):353-7. PubMed ID: 2822559
[TBL] [Abstract][Full Text] [Related]
6. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
7. Characterization of peptide-YY release in response to intracolonic infusion of amino acids.
Zhang T; Brubaker PL; Thompson JC; Greeley GH
Endocrinology; 1993 Feb; 132(2):553-7. PubMed ID: 8093875
[TBL] [Abstract][Full Text] [Related]
8. The peripheral modulation of duodenal and colonic motility in rats by the pancreatic polypeptide-fold family: neuropeptide Y, peptide YY, and pancreatic polypeptide.
Wager-Pagé SA; Ghazali B; Anderson W; Veale WL; Davison JS
Peptides; 1993; 14(2):153-60. PubMed ID: 8483795
[TBL] [Abstract][Full Text] [Related]
9. Pituitary adenylate cyclase activating polypeptide stimulates release of peptide YY.
Zhang T; Gomez G; Yanaihara N; Mochizuki T; Thompson JC; Greeley GH
Am J Physiol; 1993 Jun; 264(6 Pt 1):E933-7. PubMed ID: 8101430
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements of peptide YY for biological activity at enteric sites.
Yoshinaga K; Mochizuki T; Yanaihara N; Oshima K; Izukura M; Kogire M; Sumi S; Gomez G; Uchida T; Thompson JC
Am J Physiol; 1992 Nov; 263(5 Pt 1):G695-701. PubMed ID: 1443144
[TBL] [Abstract][Full Text] [Related]
11. Neural regulation of peptide YY secretion.
Zhang T; Uchida T; Gomez G; Lluis F; Thompson JC; Greeley GH
Regul Pept; 1993 Nov; 48(3):321-8. PubMed ID: 8278624
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
13. Human pancreatic polypeptide, neuropeptide Y and peptide YY reduce the contractile motility by depressing the release of acetylcholine from the myenteric plexus of the guinea pig ileum.
Takahashi T; Yamamura T; Utsunomiya J
Gastroenterol Jpn; 1992 Jun; 27(3):327-33. PubMed ID: 1624076
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon.
Ballantyne GH; Goldenring JR; Fleming FX; Rush S; Flint JS; Fielding LP; Binder HJ; Modlin IM
Am J Physiol; 1993 May; 264(5 Pt 1):G848-54. PubMed ID: 8388641
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
Lüers C; Gardemann A; Miura H; Jungermann K
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic inhibitory effects of the peptides NPY, PYY and PP on nicotinic EPSPs in guinea-pig gastric myenteric neurones.
Schemann M; Tamura K
J Physiol; 1992; 451():79-89. PubMed ID: 1403832
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
18. Spinal modulation of duodenal and colonic motility and arterial pressure by neuropeptide Y, neuropeptide Y fragment 13-36, peptide YY, and pancreatic polypeptide in rats: involvement of the cholinergic nervous system.
Wager-Pagé SA; Raizada E; Veale WL; Davison JS
Can J Physiol Pharmacol; 1993 Feb; 71(2):112-9. PubMed ID: 8319134
[TBL] [Abstract][Full Text] [Related]
19. Peptide YY inhibits the insulinotropic action of gastric inhibitory polypeptide.
Guo YS; Singh P; Draviam E; Greeley GH; Thompson JC
Gastroenterology; 1989 Mar; 96(3):690-4. PubMed ID: 2644149
[TBL] [Abstract][Full Text] [Related]
20. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
